TY - JOUR
T1 - Lateral and Vertical Flow Assays for Point-of-Care Diagnostics
AU - Jiang, Nan
AU - Ahmed, Rajib
AU - Damayantharan, Mylon
AU - Ünal, Barış
AU - Butt, Haider
AU - Yetisen, Ali K.
N1 - Publisher Copyright:
© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
PY - 2019/7/25
Y1 - 2019/7/25
N2 - Lateral flow assays (LFAs) have been the pillar of rapid point-of-care (POC) diagnostics due to their simplicity, rapid process, and low cost. Recent advances in sensitivity, selectivity, and chemical stability enhancement have ensured the foothold of LFAs in commercial POC diagnostics. This paper reviews recent developments in labeling strategies and detection methods of LFAs. Moreover, vertical flow assays (VFAs) have emerged as an alternate paper-based assay due to faster detection time and unique multiplexing capabilities. Smartphones as LFA readers have been transformed into a universal integrated platform for imaging, data processing, and storage, providing quantitative results in low-resource settings. Commercial LFAs and VFAs products are evaluated with regards to their performance, market trends, and regulatory issues. The future outlook of the flow-based assays for POC diagnostics is also discussed.
AB - Lateral flow assays (LFAs) have been the pillar of rapid point-of-care (POC) diagnostics due to their simplicity, rapid process, and low cost. Recent advances in sensitivity, selectivity, and chemical stability enhancement have ensured the foothold of LFAs in commercial POC diagnostics. This paper reviews recent developments in labeling strategies and detection methods of LFAs. Moreover, vertical flow assays (VFAs) have emerged as an alternate paper-based assay due to faster detection time and unique multiplexing capabilities. Smartphones as LFA readers have been transformed into a universal integrated platform for imaging, data processing, and storage, providing quantitative results in low-resource settings. Commercial LFAs and VFAs products are evaluated with regards to their performance, market trends, and regulatory issues. The future outlook of the flow-based assays for POC diagnostics is also discussed.
KW - commercialization
KW - lateral flow assays
KW - medical testing
KW - point-of-care diagnostics
KW - vertical flow assays
UR - http://www.scopus.com/inward/record.url?scp=85065774835&partnerID=8YFLogxK
U2 - 10.1002/adhm.201900244
DO - 10.1002/adhm.201900244
M3 - Review article
C2 - 31081270
AN - SCOPUS:85065774835
SN - 2192-2640
VL - 8
JO - Advanced Healthcare Materials
JF - Advanced Healthcare Materials
IS - 14
M1 - 1900244
ER -